Friday, November 13, 2026

Gold Bullish Momentum: 0.36% Up Since The Last Session

ViaNews Editorial Team

January 19, 2021

Gold Bullish Momentum: 0.36% Up Since The Last Session

Gold is currently on bullish momentum. At 19:00 EST on Monday, 18 January, Gold is at $1,836.50 and 0.36% up since the last session's close.

Gold Range

Gold is 0.79% up from its last session low of $1,822.10 and 1.083% down from its last session high of $1,856.60.

Gold is 1.08% down from its last three sessions higher value of $1,856.60 and is 0.79% up from its last three sessions lower value of $1,822.10.

Gold is 4.27% down from its last seven sessions higher value of $1,918.40 and is 0.79% up from its last seven sessions lower value of $1,822.10.

Gold is 6.25% down from its last month's higher value of $1,959.00 and is 0.79% up from its last month's lower value of $1,822.10.

Volatility

Gold's last day, last week, and last month's average volatility was a negative 1.24%, a negative 0.04%, and a positive 0.20%, respectively.

Gold's last day, last week, and last month's high and low average amplitude percentage was 1.89%, 0.54%, and 0.63%, respectively.

Last news about Gold

Nulegacy gold reports closing 100 million units PP. According to Business Insider on Saturday, 16 January, "VANCOUVER, British Columbia, Jan. 15, 2021 (GLOBE NEWSWIRE) -- NuLegacy Gold Corporation is pleased to report the closing of the 100,000,000 units (the "Units") private placement at a price of C$0.125 per Unit to raise gross proceeds to the Company of C$12.5 million (the "Offering") announced January 9, 2021.", "The Rift Anticline target islocated on trend and adjacentI to the three, multi-million ounce Carlin-type gold deposits (the Pipeline, Cortez Hills and Goldrush deposits) which are ranked amongst the world's thirty largest, lowest cost and politically safest gold mines and are three of Nevada Gold Mines' most profitable mines. II"

Caldas gold receives technical approval for marmato mining title extension. According to Business Insider on Monday, 18 January, "Additional information on Caldas Gold can be found on its website at www.caldasgold.ca and by reviewing its profile on SEDAR at www.sedar.com.", "The Company expects that the extension process will be completed before the end of January at which time it will proceed with the closing of the Aris Gold transaction."

Gold standard ventures to present at the TD securities mining conference. According to Business Insider on Monday, 18 January, "VANCOUVER, British Columbia, Jan. 18, 2021 (GLOBE NEWSWIRE) -- Gold Standard Ventures Corp. (NYSE AMERICAN: GSV) (TSX: GSV) ("Gold Standard" or the "Company") announced today that Jason Attew, President and CEO, will present virtually at the TD Securities Mining Conference on Wednesday, January 27, 2021 at 1:40 p.m. ET.", "The project is part of a +21,000 hectare land package on the Carlin Trend, and is 100% owned by Gold Standard. "

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,577 source documents archived
Query this data → isubstrate.com